Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Infusystems Holdings (INFU)

Infusystems Holdings (INFU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Infusystems Holdings 3851 West Hamlin Road Rochester Hills MI 48309 USA

www.infusystem.com Employees: 473 P: 248-291-1210

Sector:

Medical

Description:

InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.

Key Statistics

Overview:

Market Capitalization, $K 188,202
Enterprise Value, $K 204,642
Shares Outstanding, K 20,215
Float, K 17,910
% Float 88.60%
Short Interest, K 111
Short Float 0.55%
Days to Cover 1.00
Short Volume Ratio 0.72
% of Insider Shareholders 11.40%
% of Institutional Shareholders 71.13%

Financials:

Annual Sales, $ 143,440 K
Annual Net Income, $ 6,630 K
Last Quarter Sales, $ 36,230 K
Last Quarter Net Income, $ 2,040 K
EBIT, $ 11,920 K
EBITDA, $ 25,300 K

Growth:

1-Year Return 72.43%
3-Year Return 20.38%
5-Year Return -52.97%
5-Year Revenue Growth 47.28%
5-Year Earnings Growth -61.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.11 on 11/04/25
Next Earnings Date 05/14/26
Earnings Per Share ttm 0.32
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year 150.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

INFU Ratios

Ratio
Price/Earnings ttm 29.09
Price/Earnings forward 23.87
Price/Earnings to Growth N/A
Return-on-Equity % 11.91%
Return-on-Assets % 6.55%
Profit Margin % 4.62%
Debt/Equity 0.34
Price/Sales 1.31
Price/Cash Flow 9.47
Price/Book 3.30
Book Value/Share 2.82
Interest Coverage 9.17
60-Month Beta 1.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar